June 19, 2009

AstraZeneca Can't Exclude Diabetes Expert Witness From Seroquel Trials

As I noted yesterday, a few plaintiffs' cases against AstraZeneca over accusations that its antipsychotic Seroquel caused diabetes have been dismissed in Delaware Superior Court recently partly due to a judge's finding that one expert witness could not establish a link between the drug and diabetes. It sure made one wonder where the many thousands of other Seroquel cases were headed.

Now a judge in US District Court in Florida, where about 6,000 Seroquel cases currently reside, has ruled that AZ cannot exclude the testimony of a separate plaintiffs expert witness who will argue a link between the drug and diabetes in some patients. Donna Arnett, professor and chairwoman of the epidemiology department at the University of Alabama at Birmingham, argues that Seroquel causes metabolic changes, which can lead to diabetes.

The ruling affects only cases in federal court.

According to Bloomberg, Tony Jewell, an AZ spokesman, said in an emailed statement:

"'The heart of these cases are unproven claims that Seroquel causes diabetes in individual patients.'

"'Judges at both the federal and state levels have dismissed the initial cases prepared for trial, concluding that plaintiffs did not have sufficient evidence to establish that Seroquel was responsible for their alleged injuries,' he said. 'In the cases prepared for trial to date, plaintiffs have been repeatedly unable to prove their claims in court.'"

Yes, but none of those cases have gone to trial to date or been heard by a jury. It's beginning to look as though at least some cases will go to trial, unless AZ's lawyers have further rabbits to pull out of the hat.

In an Arnett deposition released earlier this year, she called Seroquel unsafe, said it led to an increased risk of diabetes and that it hadn't helped the majority of patients in clinical trials as the majority of patients in clinical trials for the drug had dropped out of the trials.

It will indeed be interesting to see how all of this plays out.

Posted by Philip Dawdy at June 19, 2009 10:30 AM
StumbleUpon Toolbar del.icio.us Digg it reddit
Comments

I think Tony Jewell has his head up his ass for saying this:

""'The heart of these cases are unproven claims that Seroquel causes diabetes in individual patients.'"

Apparently, he is not aware of the thousands of people who never had diabetes, or even have a family history of it, before taking Seroquel. It must be a difficult task being a PR guy for the Titanic.

Posted by: Stephany at June 19, 2009 11:14 AM

Stephany,
Let's hope the next sound we hear is "Glub, glub."
Sherry

Posted by: Sherry at June 19, 2009 11:33 AM

Titanic you say?
No ones talking about the iceberg expected to come in the year 2020. Unless it is already here and we must not speak of it, lest we give it power by acknowledging it.
Is the W.H.O. data estimate true? or is it fearmongering from Pharma Co. to sell more product?

World Health Organization WHO
Page 8
Worldwide, mental and behavioural disorders represented 11% of the total disease burden in 1990, based on disability-adjusted life years. This is predicted to increase to 15% by 2020.
W.H.O. PDF LINK
http://www.wpro.who.int/NR/rdonlyres/02421D66-3336-4C76-8D59-6ADA8B53D208/0/RC5214.pdf

Posted by: markps2 at June 20, 2009 06:37 AM

Hey, I've had my share of "disability-adjusted life years." My life has been very "adjusted," thanks to my disability.
{;>)

Posted by: Sherry at June 20, 2009 07:07 PM

Those WHO numbers are sooooo outdated. As soon as the new DSM is released, that statement will read:

"Worldwide, mental and behavioural disorders represented 49% of the total disease burden in 1990, based on disability-adjusted life years. This is predicted to increase to 76% by 2020."

Posted by: joe at June 23, 2009 10:13 PM
Post a comment









Remember personal info?






pic1.jpg

Patient Blogs. Sites.
Doctor Blogs. Sites.
Activists. News.
Social Networking. Forums.
Science. Big Pharma. Ethics.
Current Affairs
Seattle Stuff
Smoking. Stuff.

Info
About Furious Seasons
Email
Other Articles
ZYPREXA Documents
Alt ZYPREXA Documents Source
Blakemore-Brown Transcript

 Subscribe in a reader

Search


Recent Entries
$99 Left
$114 To Go
Winter Fundraiser, $134 To Go, Final Day
Ruth Lilly, Eli Lilly Heiress, Prozac Beneficiary Dies At 94
Winter Fundraiser, Final Day, Less Than $200 To Go
UCLA Psychiatrist Criticizes DSM-5
Winter Fundraiser, Barely $200 To Go
Most Popular Posts Of 2009
Winter Fundraiser, Less Than $300 Left, Let's Wrap It Up
Senate Health Care Bill Contains $1.25 Billion Gift To Sen. Stabenow
Travel Day, Comment Approval May Be Intermittent
Winter Fundraiser, Close But Stalled
Senate Health Care Reform Bill Contains Controversial MOTHERS Act, Abortion Study
Adult ADHD And Sleep Problems
Vic Chesnutt Dead At 45, Possible Suicide
Recent Comments

joe on AstraZeneca Can't Exclude Diabetes Expert Witness From Seroquel Trials

Sherry on AstraZeneca Can't Exclude Diabetes Expert Witness From Seroquel Trials

markps2 on AstraZeneca Can't Exclude Diabetes Expert Witness From Seroquel Trials

Sherry on AstraZeneca Can't Exclude Diabetes Expert Witness From Seroquel Trials

Stephany on AstraZeneca Can't Exclude Diabetes Expert Witness From Seroquel Trials

Archives
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
Resources
Mental Health America
National Alliance on Mental Illness
Depression and Bipolar Support Alliance
National Institute of Mental Health
McMan Web
Powered by
Movable Type 3.2